ANTITOXIN was owner-managed by professional specialists in IVD since its beginning. Lukas Quidenus succeeded Dr. Ortwin Walla, who succeeded our founder Dr. Wolfgang Helmbold. Lukas joined ANTITOXIN in 2019 following a career in pharmaceutical and IVD industry. He holds a Master of Science degree in molecular biology from Vienna University.
The every day work we successfully do for and with our customers is well described by words of Alain Merieux, the founder of bioMerieux: "We are not financial people. We are entrepreneurs in biology."